BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 89.42 thousand shares for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-31
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-05-31 was 47.92K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-02-28 was 1.13K shares, a 99.69% decline year-over-year.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-05-31 was -375.37K shares.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-02-28 was 362.00K shares, a 70.87% decline year-over-year.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2026 was 89.42K shares, a 66.74% increase from fiscal 2025.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 53.63K shares, a 67.95% decline from fiscal 2024.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 167.31K shares, a 31.15% decline from fiscal 2023.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 243.00K shares, a 29.36% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | 47.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | 49.05K shares derived: sum of 2 quarters · filed 2026-08-31 | 89.42K shares 10-K · filed 2026-08-31 | |||||
| 2026-02-28 | 1.13K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-13 | 41.50K shares 10-Q · filed 2026-04-13 | ||||||
| 2025-11-30 | 40.38K shares 10-Q · filed 2026-01-14 | |||||||
| 2025-05-31 | -375.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-31 | -13.37K shares derived: sum of 2 quarters · filed 2026-08-31 | -13.37K shares derived: sum of 3 quarters · filed 2026-08-31 | 53.63K shares 10-K · filed 2026-08-31 | ||||
| 2025-02-28 | 362.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-14 | 362.00K shares derived: sum of 2 quarters · filed 2025-04-14 | 429.00K shares 10-Q · filed 2025-04-14 | -732.19K shares derived: sum of 4 quarters · filed 2025-08-29 | ||||
| 2024-11-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-14 | 67.00K shares 10-Q · filed 2025-01-14 | -1.09M shares derived: sum of 3 quarters · filed 2025-08-29 | 148.31K shares derived: sum of 4 quarters · filed 2025-08-29 | ||||
| 2024-08-31 | 67.00K shares 10-Q · filed 2024-10-15 | -1.09M shares derived: sum of 2 quarters · filed 2025-08-29 | 148.31K shares derived: sum of 3 quarters · filed 2025-08-29 | 166.31K shares derived: sum of 4 quarters · filed 2025-08-29 | ||||
| 2024-05-31 | -1.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-29 | 81.31K shares derived: sum of 2 quarters · filed 2025-08-29 | 99.31K shares derived: sum of 3 quarters · filed 2025-08-29 | 167.31K shares 10-K · filed 2025-08-29 | 1.34M shares 10-K · filed 2024-08-28 | |||
| 2024-02-29 | 1.24M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-12 | 1.26M shares derived: sum of 2 quarters · filed 2024-04-12 | 1.33M shares 10-Q · filed 2024-04-12 | 1.43M shares derived: sum of 4 quarters · filed 2024-08-28 | ||||
| 2023-11-30 | 18.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-16 | 86.00K shares 10-Q · filed 2024-01-16 | 183.00K shares derived: sum of 3 quarters · filed 2024-08-28 | 183.00K shares derived: sum of 4 quarters · filed 2024-08-28 | ||||
| 2023-08-31 | 68.00K shares 10-Q · filed 2023-10-12 | 165.00K shares derived: sum of 2 quarters · filed 2024-08-28 | 165.00K shares derived: sum of 3 quarters · filed 2024-08-28 | |||||
| 2023-05-31 | 97.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | 97.00K shares derived: sum of 2 quarters · filed 2024-08-28 | 243.00K shares 10-K · filed 2024-08-28 | |||||
| 2023-02-28 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-04-14 | 146.00K shares 10-Q · filed 2023-04-14 | ||||||
| 2022-11-30 | 146.00K shares 10-Q · filed 2023-01-13 | |||||||
| 2022-05-31 | 37.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-25 | 344.00K shares 10-K · filed 2023-08-25 | ||||||
| 2022-02-28 | 307.00K shares 10-Q · filed 2022-04-14 | |||||||
| 2021-05-31 | 23.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-10-14 | 259.62K shares derived: sum of 2 quarters · filed 2021-10-14 | 259.62K shares derived: sum of 3 quarters · filed 2021-10-14 | 430.62K shares 10-K/A · filed 2021-10-14 | ||||
| 2021-02-28 | 236.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-14 | 236.62K shares derived: sum of 2 quarters · filed 2021-04-14 | 407.62K shares 10-Q · filed 2021-04-14 | 569.12K shares derived: sum of 4 quarters · filed 2021-04-14 | ||||
| 2020-11-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-14 | 171.00K shares 10-Q · filed 2021-01-14 | 332.50K shares derived: sum of 3 quarters · filed 2021-01-14 | |||||
| 2020-08-31 | 171.00K shares 10-Q · filed 2020-10-15 | 332.50K shares derived: sum of 2 quarters · filed 2020-10-15 | ||||||
| 2020-05-31 | 161.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-31 | 517.50K shares 10-K · filed 2020-08-31 | ||||||
| 2020-02-29 | 356.00K shares 10-Q · filed 2020-04-14 | |||||||
| 2019-05-31 | 34.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-29 | 419.00K shares derived: sum of 2 quarters · filed 2019-08-29 | 558.00K shares 10-K · filed 2019-08-29 | |||||
| 2019-02-28 | 385.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-15 | 524.00K shares 10-Q · filed 2019-04-15 | ||||||
| 2018-11-30 | 139.00K shares 10-Q · filed 2019-01-14 | |||||||
| 2018-05-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-29 | 148.00K shares derived: sum of 2 quarters · filed 2018-08-29 | 235.00K shares derived: sum of 3 quarters · filed 2019-01-14 | 287.00K shares 10-K · filed 2018-08-29 | ||||
| 2018-02-28 | 148.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-16 | 235.00K shares derived: sum of 2 quarters · filed 2019-01-14 | 287.00K shares 10-Q · filed 2018-04-16 | 287.00K shares derived: sum of 4 quarters · filed 2019-01-14 | ||||
| 2017-11-30 | 87.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-14 | 139.00K shares 10-Q · filed 2019-01-14 | 52.00K shares 10-Q · filed 2018-01-17 | 139.00K shares derived: sum of 3 quarters · filed 2019-01-14 | 139.00K shares derived: sum of 4 quarters · filed 2019-01-14 | |||
| 2017-08-31 | 52.00K shares 10-Q · filed 2017-10-16 | 52.00K shares derived: sum of 2 quarters · filed 2017-10-16 | 52.00K shares derived: sum of 3 quarters · filed 2017-10-16 | 52.00K shares derived: sum of 4 quarters · filed 2017-10-16 | ||||
| 2017-05-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-29 | 0.00 shares derived: sum of 2 quarters · filed 2017-08-29 | 0.00 shares derived: sum of 3 quarters · filed 2017-08-29 | 55.00K shares 10-K · filed 2017-08-29 | ||||
| 2017-02-28 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-14 | 0.00 shares derived: sum of 2 quarters · filed 2017-04-14 | 55.00K shares 10-Q · filed 2017-04-14 | 330.00K shares derived: sum of 4 quarters · filed 2017-04-14 | ||||
| 2016-11-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-17 | 55.00K shares 10-Q · filed 2017-01-17 | 330.00K shares derived: sum of 3 quarters · filed 2017-01-17 | |||||
| 2016-08-31 | 55.00K shares 10-Q · filed 2016-10-17 | 330.00K shares derived: sum of 2 quarters · filed 2016-10-17 | ||||||
| 2016-05-31 | 275.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | 345.00K shares 10-K · filed 2016-08-29 | ||||||
| 2016-02-29 | 70.00K shares 10-Q · filed 2016-04-14 | |||||||
| 2015-05-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | 331.50K shares derived: sum of 2 quarters · filed 2015-08-31 | 356.00K shares 10-K · filed 2015-08-31 | |||||
| 2015-02-28 | 331.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-14 | 356.00K shares 10-Q · filed 2015-04-14 | ||||||
| 2014-11-30 | 24.50K shares 10-Q · filed 2015-01-14 | |||||||
| 2014-05-31 | 178.00K shares 10-K · filed 2014-08-29 | |||||||
| 2014-02-27 | 52.00K shares 10-Q · filed 2014-04-14 | |||||||
| 2013-11-30 | 32.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-14 | 52.00K shares 10-Q · filed 2014-01-14 | ||||||
| 2013-11-13 | 32.00K shares 10-Q · filed 2014-04-14 | |||||||
| 2013-08-31 | 20.00K shares 10-Q · filed 2013-10-15 | |||||||
| 2013-06-10 | 20.00K shares 10-Q · filed 2014-04-14 | |||||||
| 2013-05-31 | 30.00K shares 10-K · filed 2013-08-29 | |||||||
| 2012-05-31 | 412.50K shares 10-K · filed 2012-08-29 | |||||||
| 2012-04-30 | 10.00K shares 10-K · filed 2012-08-29 | 10.00K shares 10-K · filed 2013-08-29 | ||||||
| 2012-01-31 | 402.50K shares 10-K · filed 2012-08-29 | |||||||
| 2011-05-31 | 175.00K shares 10-K · filed 2012-08-29 | 348.00K shares 10-K · filed 2012-08-29 | ||||||
| 2011-02-28 | 173.00K shares 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |